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ABSTRACT
Objective: The Ministry of Health (MoH) Regulation No. 30, 2014, about Health Service Standards defines the need for routine monitoring of 
prescribing indicators for several diseases, including non-pneumonia acute respiratory tract infection (ARI).
Methods: This study compares the results of percentage analysis of the antibiotic usage in patients with non-pneumonia ARI with two methods. 
Medical record data from April 2016 were collected from Primary Health Care (Puskesmas) Palmerah, West Jakarta.
Results: Convenience sampling indicated that 14.28% of patients with non-pneumonia ARIs used antibiotics. Simple random sampling indicated 
that 25% of patients with non-pneumonia ARIs used antibiotics. Differences in sample selection methods affected the final outcome (percentage of 
patients who used antibiotics). The tolerance limit for antibiotic use in non-pneumonia ARIs established by MoH was 20%.
Conclusion: These results indicate a need for MoH guidance to pay attention to the sampling techniques used in monitoring the treatment of non-
pneumonia ARIs in Primary Health Care.
Keywords: Acute respiratory tract infection, Antibiotic, Non-pneumonia.
INTRODUCTION
Acute respiratory infections (ARIs) disease always ranked first among 
the 10 most diseases in Indonesia [1,2]. The biggest disease data on 
the outpatient in Indonesia, in 2009, placed upper respiratory infection 
in the first sequence with total cases of 488,794, whereas hospitalized 
patients were ranked seventh with total cases of 36,048 [3]. The 
prevalence data of respiratory tract infections based on the diagnosis of 
health personnel and resident’s complaints was 25% in 2013 report [4].
The high prevalence of ARIs and associated effects had led to high 
consumption of free medicines (such as anti-influenza and cough 
medicine and multivitamins) and antibiotics [5]. Excessive numbers of 
antibiotic prescriptions are dispensed to treat patients with respiratory 
tract infections, especially ARIs, although most of the causes of this 
disease were viruses. One of the causes was the clinician’s over-
expectation of antibiotics, especially to prevent bacterial secondary 
infections, which could not be prevented [5,6]. The effects were 
increased bacterial resistance and an increase in unwanted side effects. 
It is, therefore, necessary to monitor prescriptions for non-pneumonia 
ARIs [6].
ARIs were the seventh most common condition among hospitalized 
patients [7]. The high prevalence of respiratory infection and its impact 
lead to increased consumption of over-the-counter drugs, such as anti-
influenza medicine, cough medicine, multivitamins, and antibiotics [8]. 
The Ministry of Health (MoH) Regulation No. 30 (2014), on Health 
Service Standards at Puskesmas regulated use of a form to monitor the 
number of prescriptions dispensed monthly [7]. The evaluation was 
intended to assess the rational use of drugs in the service system at 
Puskesmas. The form applies to the case of non-pneumonia ARI, non-
specific acute diarrhea, and diseases of muscle tissue (myalgia). Data 
were reported to the Health Service Tribe at the city/county level in 
each region [1-3,9].
The tolerance limit for antibiotics usage in non-pneumonia ARIs 
was 20%. However, data on monitoring and evaluation resulted in 
2013 show that antibiotic user was high in non-pneumonia ARIs 
disease [3]. The highest use of antibiotics for non-pneumonia 
ARIs disease was in Nanggroe Aceh Darussalam (67.9%), whereas 
Daerah Khusus Ibukota (DKI) Jakarta was 54.5%. The highest 
number of prescription drugs was found in Bangka Belitung 
Islands (4.2), whereas DKI Jakarta was slightly above the tolerance 
level (2-9) [7].
Pharmacists with their pharmaceutical services could play a role in 
overcoming these problems by monitoring prescribing indicators. 
However, there was no standardization of sampling techniques for 
this study. Therefore, this study was conducted to compare the results 
of percentage analysis of the antibiotic usage in patients with non-
pneumonia ARIs using the two methods; convenience sampling and 
simple random sampling.
METHODS
This research was an observational research with cross-sectional 
method, conducted in April 2016, at Pharmacy of the Puskesmas 
Palmerah-West Jakarta. Data were collected from the daily prescription 
and were transferred to the monitoring form prescribing indicator.
In thist study, we used the sample size determined by the MoH in which 
one prescription per day for 7 days. As comparison, we calculated 
sample size for proportion estimation of a known population (Fig. 1).
In total, the required sample size was 80 subjects. By adding the 
possibility of sample dropped out for 4%, the total sample size was 84 
subjects. The inclusion criteria were prescriptions containing ambroxol 
in April 2016 and could be read well.
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Sampling technique
The sampling technique used was convenience sampling technique 
(method 1) and simple random sampling technique (method 2). The 
research flowchart can be seen in Fig. 2.
Method 1 was a routine method at Puskesmas Palmerah. The selected 
sample was one prescription of non-pneumonia ARIs obtained at first, 
every day for 7 days. The prescribing indicator monitor form was 
following the filling out instruction below:
a) Patients were taken from the daily register, one case per day for 
each selected diagnosis. Data were collected 25 cases per selected 
diagnosis per month.
b) If on that day, there was no patient with the required diagnosis, the 
column was emptied and filled with the same diagnosis taken in the 
following days.
c) For each diagnosis, the patient was taken at first register on the day 
of recording. Diagnosis taken was single, not double, or accompanied 
by disease/other complaints.
d) Powder drugs and combination drugs were written with the details 
of the type of medicine.
e) Types of drugs included medication, injections, and external drugs.
f) Immunization was not included in the injection category.
g) The term of antibiotics included chemotherapy and anti-amoeba.
h) The “compatibility with the guidelines” column was cleared. This 
column would be filled by the supervisor at the time of supervision 
visit (10 samples were taken randomly for discussion).
Method 2 was a simple random sampling technique. A total of 482 
prescriptions were sorted by day, from number one to the last. It was 
then drawn to get a representative of 12 numbers every day for 7 
days. Therefore 84 prescriptions were obtained. The draw of the script 
number to be taken was the prescription number, as shown in Table 1.
RESULTS AND DISCUSSION
The data studied from daily at Pharmacy. Due to the limited number of 
drugs available in Puskesmas, the prescription that fell into the category 
of samples was daily prescription containing ambroxol as the only 
non-pneumonial ARIs drug available at Puskesmas Palmerah. Some 
other supportive anti-inflammatory drugs were chlorpheniramine or 
loratadine, corticosteroids such as prednisone, and vitamins such as 
Vitamin B complex and Vitamin C. The antibiotic therapy prescribed 
most commonly was amoxicillin.
The sample size at Puskesmas Palmerah on April 18–24, 2016, when 
using convenience sampling amounted to seven prescriptions. Among 
all scripts, there were antibiotics (14.28%). The total medicinal items 
of all prescriptions are 20 prescriptions, so the average daily drug item 
was 2.85. The data could be seen in Table 2.
The total prescription of non-pneumonial ARIs using simple random 
sampling showed that sample size was 84 prescriptions. Among all 
Fig. 1: The sample size calculation
n = Sample size expected, p = The proportion of antibiotic used 
in ARIs patients (set at 50% because no previous data were 
available), 1-p = The proportion of patients that did not use the 
antibiotics in patients with ARIs=1-P=50%, Z1-α/2 = Normal 
standard deviation for α 5%=1.96, d = The desired level of 
absolute precision=0.05, N=Population = 482
Sampling Method 1:
One prescription of non-pneumonia 
ARIs obtained at first, every day for 7 
days.
Sampling Method 2:
Total prescriptions were sorted by day, from 
number one to the last. It was then drawn to get
a representative of 12 prescriptions every day
for 7 days. A total of 84 prescriptions was 
obtained.
Data comparison
Collection of prescription of non-
pneumonia ARIs
(18, 19, 20, 21, 22, 23, and 24 April 
2016)
Calculation of:
1. Average number of drugs item
2. Percentage of antibiotics usage
Calculation of:
1. Average number of drugs item
2. Percentage of antibiotics usage
Fig. 2: Research flow chart
Table 1: Prescription number of draw results
Date Prescription number
April 18, 2016 12, 72, 62, 29, 8, 14, 83, 47, 63, 73, 70, 64
April 19, 2016 32, 24, 59, 35, 11, 56, 23, 10, 55, 7, 18, 27
April 20, 2016 44, 25, 15, 51, 18, 4, 3, 42, 56, 5, 20, 12
April 21, 2016 57, 56, 3, 4, 64, 60, 50, 31, 44, 73, 7, 16
April 22, 2016 15, 39, 91, 22, 86, 5, 66, 18, 17, 21, 11, 69
April 23, 2016 50, 43, 42, 28, 51, 29, 1, 19, 36, 22, 4, 8
April 24, 2016 16, 36, 10, 6, 30, 37, 13, 47, 19, 24, 8, 1
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prescriptions, 21 (25%) were antibiotics, for patients diagnosed with 
non-pneumonial ARIs. The total drug item of all prescriptions was 
247, so the average daily drug item was 2.94. The data could be seen 
in Table 3.
The World Health Organization (1985) defines the rational use of drugs 
as whether the patient receives a drug that suits his or her needs for an 
adequate period at a price affordable to him or her and the community. 
The irrational use of drugs is an important issue that may decrease the 
quality of health services by increasing microbial resistance [9].
Acute infections that attacked one or more of the respiratory tract from 
the nose to the alveoli include the adnexa (sinus, middle ear cavity, and 
pleura). Signs and symptoms of respiratory infections could include 
cough, difficulty in breathing, sore throat, runny nose, earache, and fever. 
However, airway infections therapy was not only depend on antibiotics. 
Some cases of acute respiratory infections were caused by viruses that 
did not require antibiotic therapy, but simply with supportive therapy.
According to the MoH protocol for management of ARIs, verification 
of infection is crucial before starting therapy [1,3,9]. This was because 
there were some diseases and drugs that could provide symptoms 
similar to infections. In addition, the use of antibiotics without 
evidence-based infections could lead to the increased incidence of 
resistance or potential drug resistance experienced by patients [10]. 
The symptoms of infection such as fever, leukocytosis, inflammation at 
the site of infection, infiltrate production from the site of infection need 
to be confirmed by a culture test results. Patients with non-pneumonia 
ARIs typically did not require antibiotic treatment.
Monitoring and evaluation of rational drug usage comprised three 
stages: Recording patient status, monitoring and evaluation of 
prescribing indicators, and collection of prescribing data [9]. The 
first stage was to record the patient’s status. This was done to obtain 
preliminary patient data on patient demographic data, current patient 
condition, and history of patient treatment. The second stage was 
monitoring and evaluation of prescribing indicators. Cases included 
in the monitoring form of prescribing indicators were those who seek 
treatment at Puskesmas with a single diagnosis of non-pneumonia 
(colds), non-specific acute diarrhea, and muscular, and tissue system 
diseases (myalgia). The selection of the three diagnoses was based on 
the 10 most common diseases; the diagnosis could be enforced by the 
officer without the need for an investigation, therapeutic guidelines 
for the three clear diagnoses, no antibiotics/injection required, and all 
three were considered had potency to be treated irrationally [9]. At this 
stage, an assessment of four prescribing indicators (median number 
of medicines per patient, percentage of antibiotics usage, percentage 
of injection used, and percentage of generic drug used) from incoming 
prescriptions. The third stage was collected prescribing data. Data 
recapitulation was conducted only after patient information had 
been obtained, and the patient’s prescription had been assessed. The 
format used as reference format for data recapitulation was the form 
of prescription indicator monitoring conducted by filling column 1–13; 
column 1–9 was used for monitoring purposes; and columns 10–13 
were used to assess compliance with prescribing treatment guidelines, 
under the supervision of the district health office.
The average number of drug items in the patients required by the 
directorate general of pharmaceutical and medical devices was 2.6 items 
as a tolerance limit. The results of the report at Puskesmas Palmerah 
using the first sampling method were 2.85 items, whereas when using 
the second sampling method was 2.94. Both data concluded that the 
median number of drug items administered for non-pneumonial ARIs 
was still above the required amount. It was very difficult to decrease 
the median number of medication items on non-pneumonia ARIs 
prescriptions, as they were often caused by allergies, which required 
additional drugs such as antihistamines and vitamin supplementation 
to speed the healing process.
The use of drugs for non-pneumonia ARI treatment was rational when 
convenience sampling was used but irrational when simple random 
sampling was used. The difference in outcomes of the percentage of 
antibiotic usage was seen to be very significant, due to differences in 
methods of sampling. Convenience sampling was less representative 
of the prescription per day because the sample used was very small, 
that is, one prescription. The retrieval technique used was also difficult 
to rely on because not all prescriptions had the same chance of being 
selected into a sample (non-probability). These techniques could save 
costs and time. Convenience sampling does not yet reflect the results 
of calculating the percentage of antibiotic used for patients with non-
pneumonia ARIs.
The patient’s name, age, and prescribed medications along with the 
number and rules of used could be obtained with valid data as they 
related to prescriptions brought by the patient, but for the diagnosis, 
the officer only wrote the patient’s diagnosis regardless of the patient’s 
status or medical records directly. The written prescription indicator 
form was based solely on data listed on the patient’s prescription 
because the pharmacist often had difficulty in viewing the patient’s 
medical status or records required for reporting. For example, the 
possibility of the patient had previous treatment, but 3–4 days later had 
not healed so that the next treatment was given antibiotics.
These issues demonstrate the need for an integrated computerized 
system that allows health-care practitioners to directly access patient 
data. If the pharmaceutical department could access patient data from 
a history of illness, doctor’s diagnosis, laboratory results, and nutrition 
consultation data provided by other health workers at the Puskesmas, 
Table 2: Sample data obtained with convenience sampling
No. Date Number of drugs item Antibiotics usage
1. April 18, 2016 4 1
2. April 19, 2016 2 0
3. April 20, 2016 4 0
4. April 21, 2016 3 0
5. April 22, 2016 3 0
6. April 23, 2016 2 0
7. April 24, 2016 2 0
Total 20 1
Table 3: Rational drug use report data using simple random sampling
No. Date Number of prescriptions Number of drugs item Number of antibiotics
1. April 18, 2016 12 38 3
2. April 19, 2016 12 39 2
3. April 20, 2016 12 39 6
4. April 21, 2016 12 29 1
5. April 22, 2016 12 37 2
6. April 23, 2016 12 32 3
7. April 24, 2016 12 33 4
Total 84 247 21
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then rational treatment would work better. Computerized data access 
also simplifies the workload of pharmacists and pharmacist assistants 
who work on the service system and reporting.
CONCLUSION
Convenience sampling does not yet reflect the results of calculating the 
percentage of antibiotic used for patients with non-pneumonia ARIs. 
Differences in the sample selection method affected the outcome of a 
significant percentage of antibiotic usage. Therefore, further guidance 
by the MoH related to uniformity in sampling techniques is required to 
monitor the treatment of non-pneumonia ARIs in Puskesmas.
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